Skip to content
← Back to this collection

PUBLICATIONS · 22336221

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2012 Mar
First author
Belani CP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Mar;13(3):224-5. doi: 10.1016/S1470-2045(11)70398-9.
    note
    Source null
    related pmid
    22336220
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2012 Mar 06;9(4):187. doi: 10.1038/nrclinonc.2012.29.
    note
    Source null
    related pmid
    22392096
    relationship
    Comment in

Authors and identifiers

  1. name
    Belani CP
    type
    Author
  2. name
    Brodowicz T
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Krzakowski M
    type
    Author
  5. name
    Yang SH
    type
    Author
  6. name
    Franke F
    type
    Author
  7. name
    Cucevic B
    type
    Author
  8. name
    Madhavan J
    type
    Author
  9. name
    Santoro A
    type
    Author
  10. name
    Ramlau R
    type
    Author
  11. name
    Liepa AM
    type
    Author
  12. name
    Visseren-Grul C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Belani CP
    type
    Author
  2. name
    Brodowicz T
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Krzakowski M
    type
    Author
  5. name
    Yang SH
    type
    Author
  6. name
    Franke F
    type
    Author
  7. name
    Cucevic B
    type
    Author
  8. name
    Madhavan J
    type
    Author
  9. name
    Santoro A
    type
    Author
  10. name
    Ramlau R
    type
    Author
  11. name
    Liepa AM
    type
    Author
  12. name
    Visseren-Grul C
    type
    Author
bibliography ids
  1. nci-bib-53da6814bdd3457ff70ce67f
book metadata
content sha256
897e8a2535e61f0e50477778b7c851b050a6201727a808f357c4353725d15fd6
document type
citation
dois
  1. 10.1016/S1470-2045(11)70339-4
electronic publication date
display
2012 Feb 14
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22336221
immutable id
pubmed:22336221@897e8a2535e61f0e50477778b7c851b050a6201727a808f357c4353725d15fd6
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
292-9
volume
13
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Mar;13(3):224-5. doi: 10.1016/S1470-2045(11)70398-9.
    note
    Source null
    related pmid
    22336220
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2012 Mar 06;9(4):187. doi: 10.1038/nrclinonc.2012.29.
    note
    Source null
    related pmid
    22392096
    relationship
    Comment in
outcomes validated
false
pmid
22336221
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
5acfad4544e0999f1b256c2c9e6050777860c68fb1c6444ced7fef001e02a9b7
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Mar
precision
month
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22336221/
title
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.

Preserved source evidence · Not medical advice